Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)

BACKGROUND: Community-acquired pneumonia (CAP) causes a large burden of disease. Due to difficulties in obtaining representative respiratory samples and insensitive standard microbiological methods, the microbiological aetiology of CAP is difficult to ascertain. With a few exceptions, standard-of-ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Serigstad, Sondre, Ritz, Christian, Faurholt-Jepsen, Daniel, Markussen, Dagfinn, Ebbesen, Marit H., Kommedal, Øyvind, Bjørneklett, Rune O., Heggelund, Lars, Clark, Tristan W., van Werkhoven, Cornelis H., Knoop, Siri T., Ulvestad, Elling, Grewal, Harleen M. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340738/
https://www.ncbi.nlm.nih.gov/pubmed/35915452
http://dx.doi.org/10.1186/s13063-022-06467-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340738/
https://www.ncbi.nlm.nih.gov/pubmed/35915452
http://dx.doi.org/10.1186/s13063-022-06467-7

Ejemplares similares